Katarina Sjögreen Gleisner

Professor
More filtering options
  1. 2019
  2. 2018
  3. Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy

    Anna Sundlöv, Johan Gustafsson, Gustav Brolin, Mortensen, N., Hermann, R., Bernhardt, P., Svensson, J., Michael Ljungberg, Jan Tennvall & Katarina Sjögreen Gleisner, 2018 Dec 1, In : EJNMMI Physics. 5, 1, 12.

    Research output: Contribution to journalArticle

  4. EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations

    Gear, J. I., Cox, M. G., Johan Gustafsson, Katarina Sjögreen Gleisner, Murray, I., Glatting, G., Konijnenberg, M. & Flux, G. D., 2018 Dec, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2456-2474

    Research output: Contribution to journalArticle

  5. 3-D Image-Based Dosimetry in Radionuclide Therapy

    M. Ljungberg & K. Sjögreen Gleisner, 2018 Nov 1, In : IEEE Transactions on Radiation and Plasma Medical Sciences. 2, 6, p. 527-540

    Research output: Contribution to journalReview article

  6. Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals

    Wevrett, J., Fenwick, A., Scuffham, J., Johansson, L., Gear, J., Schlögl, S., Segbers, M., Katarina Sjögreen-Gleisner, Solný, P., Lassmann, M., Tipping, J. & Nisbet, A., 2018 Aug 2, In : EJNMMI Physics. 5, 1, 17.

    Research output: Contribution to journalArticle

  7. From fixed activities to personalized treatments in radionuclide therapy: lost in translation?

    Flux, G. D., K. Sjogreen Gleisner, Chiesa, C., Lassmann, M., Chouin, N., Gear, J., Bardiès, M., Walrand, S., Bacher, K., Eberlein, U., M. Ljungberg, Strigari, L., Visser, E. & Konijnenberg, M. W., 2018 Jan, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 1, p. 152-154

    Research output: Contribution to journalArticle

  8. 2017
  9. Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey

    Katarina Sjögreen Gleisner, Spezi, E., Solny, P., Gabina, P. M., Cicone, F., Stokke, C., Chiesa, C., Paphiti, M., Brans, B., Sandström, M., Tipping, J., Konijnenberg, M. & Flux, G., 2017 Dec 1, In : EJNMMI Physics. 4, 1, 28.

    Research output: Contribution to journalArticle

  10. Dosimetry-based treatment planning for molecular radiotherapy: A summary of the 2017 report from the Internal Dosimetry Task Force

    Stokke, C., Gabiña, P. M., Solný, P., Cicone, F., Sandström, M., Katarina Sjögreen Gleisner, Chiesa, C., Spezi, E., Paphiti, M., Konijnenberg, M., Aldridge, M., Tipping, J., Wissmeyer, M., Brans, B., Bacher, K., Kobe, C. & Flux, G., 2017 Nov 21, In : EJNMMI Physics. 4, 1, 27.

    Research output: Contribution to journalReview article

  11. Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details

    Flux, G. D., Verburg, F. A., Chiesa, C., Bardiès, M., Katarina Sjögreen Gleisner, Hertz, B., Konijnenberg, M., Lassmann, M., Michael Ljungberg, Luster, M., Stabin, M. & Strigari, L., 2017 May, In : Journal of Nuclear Medicine. 58, 5, p. 862

    Research output: Contribution to journalArticle

  12. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

    Chiesa, C., K. Sjogreen Gleisner, Flux, G., Gear, J., Walrand, S., Bacher, K., Eberlein, U., Visser, E. P., Chouin, N., M. Ljungberg, Bardiès, M., Lassmann, M., Strigari, L. & Konijnenberg, M. W., 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 11, p. 1783-1786 4 p.

    Research output: Contribution to journalArticle

  13. 2016
  14. Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools

    Michael Ljungberg & Katarina Sjögreen Gleisner, 2016 Nov 15, In : Biomedicines. 4, 4, p. 1-21

    Research output: Contribution to journalReview article

  15. Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer

    MINGUEZ GABINA, PABLO., Flux, G., Genollá, J., Delgado, A., Rodeño, E. & Katarina Sjögreen Gleisner, 2016 Oct 1, In : Medical Physics. 43, 10, p. 5279-5287 9 p.

    Research output: Contribution to journalArticle

  16. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

    Michael Ljungberg, Celler, A., Konijnenberg, M. W., Eckerman, K. F., Dewaraja, Y. K. & Katarina Sjögreen Gleisner, 2016, In : Journal of Nuclear Medicine. 57, 1, p. 151-162

    Research output: Contribution to journalArticle

  17. 2015
  18. Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

    MINGUEZ GABINA, PABLO., Flux, G., Genolla, J., Guayambuco, S., Delgado, A., Fombellida, J. C. & Katarina Sjögreen Gleisner, 2015, In : Medical Physics. 42, 7, p. 3969-3978

    Research output: Contribution to journalArticle

  19. Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy

    Michael Ljungberg & Katarina Sjögreen Gleisner, 2015, In : Diagnostics. 5, 3, p. 296-317

    Research output: Contribution to journalReview article

  20. 2014
  21. 2013
  22. 2012
  23. 2011
  24. Image-based patient-specific dosimetry for radionuclide therapy

    Michael Ljungberg & Katarina Sjögreen Gleisner, 2011, [Host publication title missing]. Proceeding of the International Symposium on Standards, Applications and Quality Assurance in Medical Radiation Dosimetry International Atomic Energy Agenc, p. 251-265

    Research output: Chapter in Book/Report/Conference proceedingPaper in conference proceeding

  25. 2010
  26. Extracorporeal techniques for improving radioimmunotherapy of disseminated malignant tumors

    Rune Nilsson, Garkavij, M., Lindén, O., Katarina Sjögreen Gleisner, Michael Ljungberg & Sven-Erik Strand, 2010, Targeted Radionuclide Therapy. T.W., S. (ed.). Lippincott Williams & Wilkins

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  27. 2009
  28. Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results

    Garkavij, M., Nickel, M., Katarina Sjögreen Gleisner, Michael Ljungberg, Sven-Erik Strand, Ohlsson, T. G. & Jan Tennvall, 2009, In : Neuroendocrinology. 90, 1, p. 44

    Research output: Contribution to journalPublished meeting abstract

  29. 2008
  30. Peptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results

    Garkavij, M., Katarina Sjögreen Gleisner, Nickel, M., Ohlsson, T. G., Wingårdh, K. & Jan Tennvall, 2008, In : Cancer Biotherapy and Radiopharmaceuticals. 23, 4, p. 524-525

    Research output: Contribution to journalPublished meeting abstract

  31. 2007
  32. Parametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling

    Katarina Sjögreen Gleisner, Nickel, M., Lindén, O., Erlandsson, K., Wingårdh, K. & Sven-Erik Strand, 2007, In : Journal of Nuclear Medicine. 48, 8, p. 1369-1378

    Research output: Contribution to journalArticle

  33. 2005
  34. 2003
  35. 2002
  36. 2001
  37. Image Processing for Quantitative Scintillation-Camera Imaging. Application to Radionuclide Therapy.

    Katarina Sjögreen Gleisner, 2001, Department of Radiation Physics, Lund university. 134 p.

    Research output: ThesisDoctoral Thesis (compilation)

  38. Registration of emission and transmission whole-body scintillation-camera images

    Katarina Sjögreen Gleisner, Michael Ljungberg, Wingårdh, K., Erlandsson, K. & Sven-Erik Strand, 2001, In : Journal of Nuclear Medicine. 42, 10, p. 1563-1570

    Research output: Contribution to journalArticle

  39. 1999
  40. Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas

    Lindén, O., Jan Tennvall, Cavallin-Ståhl, E., Darte, L., Garkavij, M., Lindner, K. J., Michael Ljungberg, Ohlsson, T. G., Katarina Sjögreen Gleisner, Wingårdh, K. & Sven-Erik Strand, 1999, In : Clinical Cancer Research. 5, 10 Suppl, p. 3287-3291

    Research output: Contribution to journalArticle

Previous 1 2 Next